The report provides estimate, forecast and analysis for the influenza market over a global and regional level. The influenza market is in terms of revenue (USD million), for the period from 2015 to 2020, whereas study provides significant information related to market. The study also offers important market dynamics such as Market size, production forecasts along with key factors driving and restraining the market. Additionally, the report includes the study of opportunities, which are available in the influenza market across global level. This report provides decisive view on the influenza market to the readers, which describes industry growth rate, industry capacity, and industry structure. Study of Porter&rsquos Five Forces model for the influenza market helps to understand competitive landscape in the market. Some additional parameters such as attractiveness analysis, wherein product segments are benchmarked based on their market size and growth rate, in which different segments are benchmarked related to their market size, growth rate and general attractiveness. The research provides influenza market bifurcating it into influenza viruses and its vaccines. Influenza... Research Beam Model: Research Beam Product ID: 1217157 4199 USD New
Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 - 2020
 
 

Influenza Market (H1N1 Vaccines and Others) by Product (Influenza Vaccines and Influenza Drugs): Global Industry Perspective, Comprehensive Analysis and Forecast 2014 - 2020

  • Category : Pharmaceuticals
  • Published On : October   2015
  • Pages : 112
  • Publisher : Zion Market Research
 
 
 


The report provides estimate, forecast and analysis for the influenza market over a global and regional level. The influenza market is in terms of revenue (USD million), for the period from 2015 to 2020, whereas study provides significant information related to market. The study also offers important market dynamics such as Market size, production forecasts along with key factors driving and restraining the market. Additionally, the report includes the study of opportunities, which are available in the influenza market across global level.



This report provides decisive view on the influenza market to the readers, which describes industry growth rate, industry capacity, and industry structure. Study of Porter&rsquos Five Forces model for the influenza market helps to understand competitive landscape in the market. Some additional parameters such as attractiveness analysis, wherein product segments are benchmarked based on their market size and growth rate, in which different segments are benchmarked related to their market size, growth rate and general attractiveness.



The research provides influenza market bifurcating it into influenza viruses and its vaccines. Influenza viruses includes influenza type A, influenza type B, influenza type C. All the market distribution on products and application has been analyzed based on present and future trends and the market is estimated from 2015 to 2020.



The report provides global scenario of Influenza Market comprehensive overview and market figures. Moreover, study gives the current and expected demand for main region including Americas, EMEA and Asia Pacific. The report provides detailed bifurcation of global influenza market on the basis of products type such as influenza vaccines and influenza drugs. Similar bifurcation has been provided for the individual region.



The report covers detailed competitive scenario including the market share and company overviews, financial revenues of the key participants to develop their positions in the global market. Some key players in this market include AstraZeneca, F. Hoffmann-La Roche, GlaxoSmithKline, Novartis, Sanofi-Pasteur and others.



This report segments the global market as follows:





Influenza Market - Product Segment Analysis

Influenza Vaccines

Influenza Drugs





Influenza Market &ndash Regional Analysis





Americas

EMEA (Europe, Middle East and Africa)

Asia Pacific



Table of Content Chapter 1. Preface 1.1. Report description and scope 1.2. Research methodology 1.2.1. Market research process 1.3. List of abbreviations Chapter 2. Executive Summary 2.1. Global Influenza Market Revenue, 2014 - 2020 (USD Billion) 2.2. Influenza Market: Snapshot Chapter 3. Influenza Market – Market Dynamics 3.1. Introduction 3.2. Introduction and Classification 3.2.1. Seasonal Influenza 3.2.2. Pandemic Influenza 3.2.3. Zoonotic or Variant Influenza 3.3. Influenza Season 3.4. Geographical Distribution 3.5. Market Drivers 3.5.1. Increase in Awareness Regarding Influenza 3.5.2. Increase in Industry-Academia Collaborations 3.5.3. Global Action Plan for Influenza Vaccines 3.6. Market Restraints 3.7. Market Trends 3.8. Porter’s Five Forces Analysis Chapter 4. Market Landscape 4.1. Buying Criteria 4.2. Vendor landscape 4.2.1. competitive Scenario 4.2.1.1. Key News 4.2.1.2. MA’s 4.2.2. Market Share Analysis 4.2.2.1. Sanofi Pasteur 4.2.2.2. F. Hoffmann-La Roche 4.2.2.3. GlaxoSmithKline 4.2.2.4. AstraZeneca 4.2.2.5. Novartis 4.2.3. Other Prominent Vendors Chapter 5. Market Segmentation by Type of Influenza Virus 5.1. Influenza Type A Viruses 5.2. Influenza Type B Viruses 5.3. Influenza Type C Viruses Chapter 6. Global H1N1 Vaccines Market 6.1. Market Share 6.2. Market Segmentation 6.3. Market Size and Forecast 6.4. Geographical Segmentation Chapter 7. Market Segmentation by Product Type Chapter 8. Global Influenza Drugs Market 8.1. Market Segmentation 8.1.1. M2 Protein inhibitors 8.1.2. Neuraminidase Inhibitors 8.2. Market Size and Forecast 8.3. Key Approved Influenza Drugs 8.3.1. In US 8.3.2. In EU Chapter 9. Global Influenza Vaccines Market 9.1. Market Segmentation 9.2. Market Size and Forecast 9.3. WHO Recommendation 9.4. Key Approved Influenza Vaccines 9.4.1. In US 9.4.2. In EU Chapter 10. Geographical Segmentation Chapter 11. Company Profiles 11.1. AstraZeneca 11.1.1. Key Facts 11.1.2. Business Description 11.1.3. Business Segmentation 11.1.4. Business Strategy 11.1.5. Business Segmentation by Revenue 11.1.6. Revenue Comparison 2011-2013 11.1.7. Geographical Segmentation by Revenue 11.1.8. Key Development 11.1.9. SWOT Analysis 11.2. F. Hoffmann-La Roche 11.2.1. Key Facts 11.2.2. Business Description 11.2.3. Business Segmentation by Revenue 11.2.4. Geographical Segmentation by Revenue 11.2.5. Business Strategy 11.2.6. Key Development 11.2.7. SWOT Analysis 11.3. GlaxoSmithKline 11.3.1. Key Facts 11.3.2. Business Description 11.3.3. Business Segmentation 11.3.4. Business Segmentation by Revenue 11.3.5. Geographical Segmentation by Revenue 11.3.6. Pipeline Products 11.3.7. Business Strategy 11.3.8. Key Development 11.3.9. SWOT Analysis 11.4. Novartis 11.4.1. Key Facts 11.4.2. Business Description 11.4.3. Business Segment at ion by Revenue 2013 103 11.4.4. Business Segmentation Revenue Comparison 2012-2013 11.4.5. Geographical Segmentation by Revenue 11.4.6. Business Strategy 11.4.7. Key Development 11.4.8. SWOT Analysis 11.5. Sanofi Pasteur 11.5.1. Key facts 11.5.2. Business Description 11.5.3. Business Strategy 11.5.4. Key Development 11.5.5. SWOT Analysis
PURCHASE OPTIONS
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter

 
 

Related Reports

Global Bulk Drug Market Research Report 2018

Published On : November   2018

$ 2900

$ 2900

Global IVIg Powder Market Research Report 2018

Published On : November   2018

$ 2900

Global Rituxan Market Research Report 2018

Published On : November   2018

$ 2900

Global Revlimid Market Research Report 2018

Published On : November   2018

$ 2900

REQUEST SAMPLE    ASK FOR DISCOUNT